Catalent Appoints First President of Asia Pacific Group
Catalent appoints David Heyens as President of Asia Pacific facility.
Catalent
has named David Heyens in the new role of president of Catalent Asia Pacific. Reporting directly to Catalent’s president and CEO, John Chiminski, Heyens was hired to drive Catalent’s growth in the region following the company’s recent expansion into China, and build on Catalent’s regional operations in Japan, Australia, and Singapore.
Replacing Heyens as the president of Catalent Softgel Technologies will be Aris Gennadios, PhD. Also reporting to Chiminski, Gennadios will have full strategic responsibility for the soft gel development, delivery, and supply business with 10 global manufacturing facilities that deliver pharmaceutical, generic, and consumer health soft gel products to markets worldwide.
Source:
Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
